Index RUT P/E - EPS (ttm) -1.54 Insider Own 31.08% Shs Outstand 139.25M Perf Week 9.73%
Market Cap 1.91B Forward P/E - EPS next Y -0.15 Insider Trans -0.99% Shs Float 96.36M Perf Month 1.94%
Income -186.64M PEG - EPS next Q -0.15 Inst Own 65.90% Short Float 12.55% Perf Quarter -17.87%
Sales 482.26M P/S 3.96 EPS this Y 16.32% Inst Trans 1.17% Short Ratio 7.15 Perf Half Y 43.99%
Book/sh 0.56 P/B 24.33 EPS next Y 65.14% ROA -28.31% Short Interest 12.09M Perf Year -7.14%
Cash/sh 1.58 P/C 8.64 EPS next 5Y 12.00% ROE -421.26% 52W Range 8.66 - 19.14 Perf YTD -9.66%
Dividend Est. - P/FCF - EPS past 5Y -5.07% ROI -29.33% 52W High -28.68% Beta 1.48
Dividend TTM - Quick Ratio 1.99 Sales past 5Y 40.20% Gross Margin 52.68% 52W Low 57.62% ATR (14) 0.55
Dividend Ex-Date - Current Ratio 2.86 EPS Y/Y TTM -4.73% Oper. Margin -30.75% RSI (14) 57.02 Volatility 4.21% 3.96%
Employees 839 Debt/Eq 5.33 Sales Y/Y TTM 37.45% Profit Margin -38.70% Recom 1.00 Target Price 23.41
Option/Short Yes / Yes LT Debt/Eq 5.26 EPS Q/Q -11.01% Payout - Rel Volume 0.64 Prev Close 13.21
Sales Surprise 4.61% EPS Surprise -52.67% Sales Q/Q 30.23% Earnings May 07 AMC Avg Volume 1.69M Price 13.65
SMA20 4.41% SMA50 1.44% SMA200 -1.14% Trades
Volume 1,081,648 Change 3.33%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-09-24 Initiated Wells Fargo
Overweight
$26
Dec-19-23 Reiterated Needham
Buy
$16 → $18
Oct-20-23 Initiated ROTH MKM
Buy
$22
Oct-12-22 Initiated Jefferies
Buy
$12
Sep-12-22 Initiated Morgan Stanley
Overweight
$13
Dec-03-21 Initiated Goldman
Neutral
$12.50
Oct-29-21 Initiated Loop Capital
Buy
$22
Aug-25-21 Initiated Needham
Buy
$18
Aug-04-21 Resumed Cowen
Outperform
$22.50
Mar-05-21 Reiterated H.C. Wainwright
Buy
$16 → $19
Dec-21-20 Reiterated H.C. Wainwright
Buy
$12 → $16
Oct-20-20 Initiated Stifel
Buy
$13
Sep-03-20 Initiated Cowen
Outperform
$12
Jun-18-20 Initiated Northland Capital
Outperform
$9
Aug-28-19 Initiated Canaccord Genuity
Buy
$7
Aug-05-19 Initiated Piper Jaffray
Overweight
$7
Oct-16-17 Initiated Lake Street
Buy
$7
Aug-14-17 Initiated H.C. Wainwright
Buy
$4
Aug-05-15 Downgrade Canaccord Genuity
Buy → Hold
$2.50 → $1
May-14-15 Initiated Northland Capital
Outperform
$3
Show Previous Ratings
May-02-24 09:00AM
Apr-26-24 07:00PM
04:41PM
Apr-17-24 09:00AM
Mar-10-24 03:24PM
11:54PM
Loading…
Mar-08-24 11:54PM
Mar-04-24 11:52PM
Mar-01-24 12:40AM
Feb-28-24 10:14AM
Feb-27-24 04:58PM
04:52PM
(Associated Press Finance)
04:01PM
Jan-29-24 09:00AM
Jan-08-24 09:00AM
08:00AM
09:00AM
Loading…
Dec-19-23 09:00AM
Nov-07-23 10:52AM
Nov-06-23 04:43PM
04:39PM
(Associated Press Finance)
04:05PM
Nov-01-23 09:00AM
Oct-31-23 09:00AM
Oct-27-23 04:05PM
Oct-25-23 05:38PM
Oct-24-23 10:59PM
04:01PM
Oct-23-23 07:00AM
Oct-17-23 04:05PM
09:00AM
Oct-16-23 04:05PM
09:00AM
Loading…
09:00AM
Oct-09-23 04:05PM
Oct-05-23 12:37PM
Sep-18-23 12:14PM
Sep-14-23 01:12PM
Sep-08-23 07:36PM
01:05PM
Aug-07-23 11:00AM
Aug-03-23 04:11PM
04:00PM
Jul-24-23 09:00AM
Jul-18-23 09:00AM
Jul-02-23 09:37AM
Jun-27-23 04:16PM
(Investor's Business Daily)
Jun-06-23 07:00AM
Jun-04-23 10:47AM
May-23-23 09:00AM
May-04-23 04:53PM
04:05PM
10:42AM
Apr-19-23 05:00PM
04:07PM
04:05PM
Apr-17-23 08:24AM
Apr-13-23 09:00AM
Apr-04-23 09:00AM
Mar-13-23 09:39AM
Mar-03-23 08:10PM
Feb-28-23 07:25PM
04:05PM
Feb-21-23 09:00AM
Feb-10-23 08:40AM
Feb-07-23 09:00AM
Jan-09-23 09:00AM
Jan-08-23 09:10AM
Dec-28-22 09:00AM
Dec-12-22 12:32PM
Nov-09-22 06:22AM
Nov-03-22 06:45PM
04:05PM
06:36AM
Nov-01-22 10:01AM
09:00AM
Oct-27-22 10:02AM
Oct-17-22 12:41PM
Oct-12-22 09:00AM
Oct-11-22 09:00AM
Oct-10-22 09:00AM
Oct-05-22 09:55AM
Sep-29-22 07:50AM
Sep-28-22 09:00AM
Sep-15-22 08:04PM
Aug-30-22 09:00AM
Aug-04-22 07:25PM
04:05PM
Aug-01-22 10:03AM
10:01AM
Jul-28-22 10:03AM
Jul-26-22 09:00AM
Jul-21-22 09:00AM
Jul-02-22 09:12AM
Jun-02-22 08:47AM
May-25-22 09:00AM
May-19-22 09:00AM
May-05-22 06:35PM
04:05PM
May-04-22 05:35PM
Apr-21-22 09:00AM
Apr-05-22 09:00AM
Apr-04-22 08:23AM
Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Koning John Todd CHIEF FINANCIAL OFFICER Apr 24 '24 Sale 12.82 37,500 480,750 393,356 Apr 26 04:38 PM Bakst Evan Director Mar 14 '24 Buy 13.53 15,000 202,950 15,000 Mar 18 11:35 AM Blackford Quentin S. Director Mar 07 '24 Buy 12.83 20,000 256,600 572,605 Mar 08 08:55 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Mar 06 '24 Sale 13.16 9,225 121,401 295,870 Mar 08 05:30 PM Koning John Todd CHIEF FINANCIAL OFFICER Mar 01 '24 Sale 13.30 121,601 1,617,293 430,856 Mar 04 08:43 PM Marshall Tyson Eliot GENERAL COUNSEL & CORP. SEC. Mar 01 '24 Sale 13.30 11,825 157,272 305,095 Mar 04 08:45 PM Sponsel David EVP, SALES Feb 27 '24 Sale 15.19 32,365 491,624 622,296 Feb 29 06:51 PM Lish Scott CHIEF OPERATING OFFICER Feb 27 '24 Sale 15.19 31,075 472,029 507,165 Feb 29 06:49 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 26 '24 Sale 15.05 41,560 625,478 1,188,444 Feb 28 12:21 PM Sponsel David EVP, SALES Feb 21 '24 Sale 15.34 17,820 273,359 654,661 Feb 22 06:31 PM Lish Scott CHIEF OPERATING OFFICER Feb 21 '24 Sale 15.34 11,963 183,512 538,240 Feb 22 06:30 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 20 '24 Sale 15.16 77,255 1,171,186 1,188,814 Feb 22 06:31 PM Sponsel David EVP, SALES Feb 14 '24 Sale 16.16 2,500 40,400 637,418 Feb 15 05:49 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 05 '24 Sale 16.41 500 8,205 1,266,069 Feb 05 06:46 PM Hunsaker Craig E EVP, PEOPLE & CULTURE Feb 02 '24 Sale 16.51 38,556 636,560 1,266,569 Feb 05 06:46 PM Sponsel David EVP, SALES Feb 02 '24 Sale 16.47 36,620 603,131 639,918 Feb 05 06:48 PM Lish Scott CHIEF OPERATING OFFICER Feb 02 '24 Sale 16.47 25,210 415,209 518,457 Feb 05 06:44 PM Sponsel David EVP, SALES Jan 16 '24 Sale 15.00 2,500 37,500 555,280 Jan 17 04:30 PM Sponsel David EVP, SALES Dec 21 '23 Sale 15.00 2,500 37,500 557,780 Dec 26 07:25 PM Demski David M Director Nov 09 '23 Buy 10.50 30,000 315,000 181,694 Nov 13 10:19 AM Miles Patrick CEO Sep 27 '23 Sale 13.00 59,375 771,875 5,452,736 Sep 27 06:45 PM Miles Patrick CEO Sep 26 '23 Sale 12.46 60,000 747,600 5,512,111 Sep 27 06:45 PM Miles Patrick CEO Sep 25 '23 Sale 12.51 60,000 750,600 5,572,111 Sep 27 06:45 PM Miles Patrick CEO Sep 20 '23 Sale 13.35 60,000 801,000 5,632,111 Sep 20 05:26 PM Miles Patrick CEO Sep 19 '23 Sale 13.42 60,000 805,200 5,692,111 Sep 20 05:26 PM Miles Patrick CEO Sep 18 '23 Sale 13.48 60,000 808,800 5,752,111 Sep 20 05:26 PM TULLIS JAMES L L Director Sep 11 '23 Sale 14.74 70,000 1,031,800 563,831 Sep 13 12:25 PM TULLIS JAMES L L Director Sep 11 '23 Sale 14.74 35,000 515,900 171,962 Sep 13 12:25 PM Mowry David H Director Sep 11 '23 Sale 14.46 9,500 137,370 92,381 Sep 13 12:27 PM Bakst Evan Director Aug 23 '23 Sale 14.92 8,700 129,804 1,089,038 Aug 24 08:34 PM Pritzker Jennifer N. 10% Owner Aug 10 '23 Buy 14.99 2,400 35,976 58,000 Aug 10 06:06 PM Pritzker Jennifer N. 10% Owner Aug 10 '23 Buy 14.95 2,000 29,900 8,000 Aug 10 06:06 PM Pritzker Jennifer N. 10% Owner Aug 08 '23 Buy 15.56 1,350 21,006 11,931 Aug 10 06:06 PM Hunsaker Craig E EVP, PEOPLE/CULTURE & GC Jun 28 '23 Sale 18.00 100,487 1,808,766 1,120,427 Jun 28 08:47 PM Hunsaker Craig E EVP, PEOPLE/CULTURE & GC Jun 27 '23 Sale 18.00 6,542 117,756 1,220,914 Jun 28 08:47 PM Altman Elizabeth Ann Director Jun 16 '23 Sale 16.14 9,273 149,666 31,158 Jun 20 05:08 PM Sponsel David EVP, SALES Jun 15 '23 Sale 16.17 55,577 898,680 559,840 Jun 20 12:35 PM Segal Paul Director Jun 12 '23 Sale 15.15 71,329 1,080,634 100,000 Jun 14 08:55 PM Segal Paul Director Jun 12 '23 Sale 15.15 71,329 1,080,634 100,000 Jun 16 04:54 PM TULLIS JAMES L L Director May 17 '23 Option Exercise 3.50 255,035 892,622 659,570 May 18 06:00 PM TULLIS JAMES L L Director May 17 '23 Option Exercise 3.50 6,143 21,500 198,452 May 18 06:00 PM TULLIS JAMES L L Director May 15 '23 Option Exercise 3.50 255,034 892,619 575,283 May 16 07:47 PM TULLIS JAMES L L Director May 15 '23 Option Exercise 3.50 6,143 21,500 193,701 May 16 07:47 PM Hunsaker Craig E EVP, PEOPLE/CULTURE & GC May 15 '23 Sale 15.29 58,238 890,459 1,227,456 May 16 07:45 PM Berkowitz Mortimer III Director May 12 '23 Option Exercise 3.50 107,937 377,780 663,058 May 12 06:48 PM Miles Patrick CEO May 10 '23 Option Exercise 3.50 269,842 944,447 5,872,606 May 12 06:00 PM Pritzker Jennifer N. 10% Owner May 10 '23 Buy 15.57 2,400 37,368 55,600 May 11 04:40 PM Pritzker Jennifer N. 10% Owner May 10 '23 Buy 15.71 2,000 31,420 7,000 May 11 04:40 PM L-5 Healthcare Partners, LLC Director by deputization May 10 '23 Sale 14.88 1,700,000 25,296,000 11,081,538 May 12 04:59 PM Segal Paul 10% Owner May 10 '23 Sale 14.88 167,496 2,492,340 171,329 May 12 04:59 PM Pritzker Jennifer N. 10% Owner May 09 '23 Buy 15.26 1,200 18,312 10,581 May 11 04:40 PM
Index RUT P/E - EPS (ttm) -4.22 Insider Own 1.79% Shs Outstand 30.95M Perf Week -8.25%
Market Cap 3.18B Forward P/E - EPS next Y -2.02 Insider Trans -9.22% Shs Float 30.42M Perf Month -4.31%
Income -129.96M PEG - EPS next Q -0.91 Inst Own 106.90% Short Float 9.25% Perf Quarter -14.35%
Sales 513.17M P/S 6.20 EPS this Y 20.02% Inst Trans 0.46% Short Ratio 6.09 Perf Half Y 30.11%
Book/sh 2.90 P/B 35.36 EPS next Y 37.48% ROA -19.52% Short Interest 2.81M Perf Year -22.81%
Cash/sh 18.37 P/C 5.59 EPS next 5Y - ROE -83.28% 52W Range 70.24 - 134.45 Perf YTD -4.07%
Dividend Est. - P/FCF - EPS past 5Y -13.90% ROI -16.01% 52W High -23.63% Beta 1.30
Dividend TTM - Quick Ratio 6.95 Sales past 5Y 27.64% Gross Margin 66.96% 52W Low 46.18% ATR (14) 4.57
Dividend Ex-Date - Current Ratio 7.10 EPS Y/Y TTM -21.54% Oper. Margin -21.96% RSI (14) 35.71 Volatility 4.84% 3.94%
Employees 2000 Debt/Eq 8.16 Sales Y/Y TTM 19.35% Profit Margin -25.33% Recom 1.25 Target Price 137.50
Option/Short Yes / Yes LT Debt/Eq 7.99 EPS Q/Q -14.01% Payout - Rel Volume 1.91 Prev Close 110.88
Sales Surprise 2.74% EPS Surprise -51.14% Sales Q/Q 18.39% Earnings May 02 AMC Avg Volume 461.93K Price 102.68
SMA20 -8.57% SMA50 -7.50% SMA200 1.04% Trades
Volume 884,211 Change -7.40%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-11-23 Upgrade Citigroup
Neutral → Buy
$110
Jul-19-23 Initiated Robert W. Baird
Outperform
$130
Feb-07-23 Initiated Wells Fargo
Overweight
$150
Nov-07-22 Upgrade Wolfe Research
Underperform → Peer Perform
Jun-09-22 Downgrade Citigroup
Buy → Neutral
$180 → $155
Apr-06-22 Initiated Wolfe Research
Underperform
$105
Feb-24-22 Upgrade Needham
Hold → Buy
$135
Feb-24-22 Upgrade Needham
Hold → Buy
Jan-18-22 Upgrade Morgan Stanley
Equal-Weight → Overweight
$129 → $167
Jan-12-22 Upgrade BTIG Research
Neutral → Buy
$170
Jan-11-22 Upgrade Oppenheimer
Perform → Outperform
$150
Dec-21-21 Resumed Canaccord Genuity
Buy
$125
Dec-17-21 Upgrade JP Morgan
Neutral → Overweight
$100 → $116
Dec-15-21 Upgrade Citigroup
Neutral → Buy
$120
Jun-02-21 Downgrade Citigroup
Buy → Neutral
$105 → $78
Apr-13-21 Downgrade BTIG Research
Buy → Neutral
Apr-12-21 Downgrade JP Morgan
Overweight → Neutral
Feb-26-21 Downgrade Colliers Securities
Buy → Neutral
Jan-29-21 Reiterated Needham
Hold
Nov-17-20 Downgrade Oppenheimer
Outperform → Perform
Show Previous Ratings
May-03-24 10:05AM
07:05AM
(Thomson Reuters StreetEvents)
May-02-24 10:54PM
05:39PM
04:05PM
09:45AM
Loading…
09:45AM
Apr-23-24 12:35PM
Apr-18-24 04:05PM
Apr-08-24 04:09AM
Apr-01-24 05:45AM
Mar-20-24 05:45AM
Mar-13-24 11:30AM
Mar-08-24 04:30PM
Mar-05-24 11:29PM
Mar-04-24 11:42PM
06:45AM
Loading…
06:45AM
Feb-29-24 04:30PM
Feb-23-24 12:30PM
11:06AM
05:45AM
Feb-22-24 05:50PM
04:36PM
04:05PM
Feb-20-24 01:59PM
05:45AM
Feb-08-24 04:05PM
Jan-14-24 12:54PM
Jan-08-24 08:30AM
Jan-05-24 08:05AM
Jan-04-24 07:01PM
08:00AM
Loading…
Jan-03-24 08:00AM
Dec-26-23 04:30PM
Nov-13-23 08:05AM
Nov-03-23 10:41AM
09:44AM
(Thomson Reuters StreetEvents)
Nov-02-23 06:22PM
04:05PM
Oct-31-23 10:01AM
Oct-27-23 09:35AM
Oct-26-23 10:02AM
Oct-19-23 04:05PM
Sep-28-23 08:23AM
Sep-27-23 07:35PM
Sep-26-23 08:05AM
Sep-22-23 11:47AM
Aug-29-23 08:30AM
Aug-23-23 06:00AM
Aug-04-23 10:45AM
(Simply Wall St.) +18.26%
Aug-03-23 05:55PM
04:10PM
04:05PM
Jul-26-23 04:24PM
(The Wall Street Journal)
Jul-20-23 04:05PM
Jul-18-23 08:30AM
Jun-14-23 09:23AM
Jun-06-23 09:00AM
May-27-23 08:28AM
May-24-23 04:05PM
May-22-23 08:30AM
May-11-23 06:09AM
May-04-23 06:05PM
04:05PM
Apr-20-23 04:05PM
Apr-14-23 06:51PM
Apr-13-23 12:21PM
Apr-12-23 04:30PM
Apr-02-23 02:07PM
Mar-14-23 07:42AM
Mar-06-23 08:30AM
Mar-02-23 08:30AM
Feb-25-23 08:04AM
Feb-24-23 02:44PM
Feb-23-23 04:05PM
Feb-21-23 06:57AM
Feb-09-23 04:05PM
Jan-09-23 08:30AM
Dec-27-22 04:30PM
Dec-01-22 01:54PM
Nov-14-22 10:43AM
Nov-07-22 04:05PM
Nov-06-22 12:30PM
Nov-04-22 11:47AM
Nov-02-22 05:45PM
08:30AM
06:28AM
Nov-01-22 05:45PM
04:05PM
Oct-20-22 04:05PM
Sep-21-22 08:30AM
Aug-31-22 08:30AM
Aug-06-22 05:00AM
Aug-05-22 10:27AM
Aug-04-22 07:15PM
04:05PM
Jul-28-22 04:30PM
10:02AM
Jul-25-22 04:15PM
Jul-22-22 04:52PM
(American City Business Journals)
08:30AM
Jul-18-22 04:10PM
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Blackford Quentin S. President and CEO Mar 04 '24 Sale 111.14 4,221 469,122 175,794 Mar 05 04:52 PM Day Mark J. Chief Technology Officer Mar 04 '24 Sale 111.14 3,248 360,983 61,164 Mar 05 04:53 PM Wilson Daniel G. EVP, Corp Dev Inv Rel Mar 04 '24 Sale 111.14 2,452 272,515 30,515 Mar 05 04:50 PM Bobzien Brice Chief Financial Officer Mar 04 '24 Sale 111.14 1,401 155,707 25,800 Mar 05 04:50 PM Patterson Chad Chief Commercial Officer Mar 04 '24 Sale 111.14 1,077 119,698 39,865 Mar 05 04:52 PM Turakhia Minang EVP, CMO & CSO Mar 04 '24 Sale 111.14 943 104,805 28,659 Mar 05 04:50 PM Shrishrimal Sumi EVP, Chief Risk Officer Mar 04 '24 Sale 111.14 723 80,354 24,429 Mar 05 04:49 PM Blackford Quentin S. President and CEO Feb 29 '24 Sale 121.96 24,701 3,012,534 180,015 Mar 01 07:19 PM Murphy Patrick Michael CBO and CLO Feb 29 '24 Sale 121.96 7,615 928,725 48,962 Mar 01 07:19 PM Day Mark J. Chief Technology Officer Feb 29 '24 Sale 121.96 1,475 179,891 64,412 Mar 01 07:18 PM Wilson Daniel G. EVP, Corp Dev Inv Rel Feb 29 '24 Sale 121.96 1,261 153,792 32,967 Mar 01 07:18 PM Wilson Daniel G. EVP, Corp Dev Inv Rel Jan 02 '24 Sale 103.31 7,218 745,692 26,629 Jan 04 11:57 AM Bobzien Brice Chief Financial Officer Aug 09 '23 Sale 111.29 1,356 150,909 18,608 Aug 10 04:20 PM Day Mark J. Chief Technology Officer Aug 03 '23 Option Exercise 36.22 486 17,603 55,522 Aug 04 08:48 AM Shrishrimal Sumi EVP, Chief Risk Officer Jun 02 '23 Sale 111.45 1,109 123,598 18,707 Jun 05 04:07 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
